Page 516 - Multidisipliner Covid 19

BÖLÜM 29

3. He W. Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X,
Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP. COVİD-19 in persons with
haematologicalcancers. Leukemia 2020. Doi. Org/10.1038/s41375-020-
0836-7.
4. Martin-Moro F, Marquet J, Piris M, Michael BM, Saez AJ, Corona M,
Jimenez C, Astibia B, Garcia I, Rodriguez E, Garcia-Hoz C, Fortun-
Abete J, Herrera P, Lopez-Jiminez J. Survival study of hospitalized
patients with concurrent COVID-19 and haematological malignancies.
Letters, doi: 10.111/bjh.1680.
5. Tal S, Spectre G, Kornowski R, Perl L. Venous Thromboembolism com-
plicated with COVİD-19: What Do We know so far? Acta Hematologica
2020, DOİ: 10.1159/000508233.
6. Debuc B, Smadja DM. Is COVİD-19 a newhematologicdisease?Stem
Cell RevRep. 2020 May 12. Doi: 10.1007/s12015-020-09987-4. (Epubahead
of print)
7. Abruzzese E, Luciano L, D’Agostino F, Trawinska MM, Pane F, Fabritiis
PD. SARS-CoV-2 (COVİD-19) and chronic myeloid leukemia (CML):
a Case report and review of ABL kinase involvement in viral infection.
Mediterr J Hematol Infect Dis 2020, 12 (1): e2020031, DOİ: 10.4084/
MJHID. 2020.031.
8. McGonagle D, Sharif k, O’Regan A, Bridgewood C. The role of cytokines
including Interleukin-6 in COVİD-19 induced pneumonia and macro-
phage activation syndrome-like disease. Autoimmunity Reviews 2020.
Doi: 10.1016/j.autrev.2020.102537.
9. Leisman DE, Deutschman CS, Legrand M. Facing COVİD-19 in the
ICU: vascular dysfunction, thrombosis, and dysregulated inflammation.
IntensiveCareMed 2020. Doi: 10.1007/s00134-020-06059-6.
10.Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal stem cell
therapy for COVID-19: Present or future. Stem Cell Reviews and Reports
2020. Doi: 10.1007/s12015-020-09973-w.
11.Weinkove R, McQuilten ZK, Adler J, Agar MR, Blyth E, Cheng AC,
Conyers R, Haeusler GM, Hardie C, Jackson C, Lane SW, Middlemiss
T, Mollee P, Mulligan SP, Ritchie D, Ruka M, Solomon B, Szer J, Thursky
KA, Wood EM, Worth LJ, Yong MK, Slavin MA, Teh BW. Managing
haematology and oncology patients during the COVID-19 pandemic:
interim concensus guidance. Med J Aust 2020 May 13. Doi: 10.5694/mja2.
50607. (Epubahead of print) .

515